Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation

NCT03402776 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Haemopoietic Stem Cell Transplantation
Allograft

Interventions

DRUG: 4th dose of hexavalent vaccine 1 month after the 3rd dose

Sponsor

University Hospital, Grenoble

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]